| CPC C12P 13/04 (2013.01) [C12N 9/88 (2013.01); C12N 15/70 (2013.01); C12P 13/225 (2013.01); C12N 15/1034 (2013.01); C12Y 401/99002 (2013.01); C40B 40/08 (2013.01)] | 22 Claims |
|
1. An engineered polypeptide that catalyzes the synthesis of L-tyrosine in enantiomeric excess, said polypeptide comprising an amino acid sequence having at least one amino acid substitution relative to SEQ ID NO: 2, wherein said at least one amino acid substitution is selected from the group consisting of X132R, X354P, X454E, and combinations thereof, further wherein said amino acid sequence is selected from the group consisting of SEQ ID No: 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 226, 228, 230, 232, 234, 236, 238, 240, 242, 244, 246, 248, 250, 252, 254, 256, 258, 260, 262, 264, 266, 268, 270, 272, 274, 276, 278, 280, 282, 284, 286, 288, 290, 292, 294, 296, 298, 300, 302, 304, 306, and 308.
|